Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
154 participants
INTERVENTIONAL
2007-05-16
2024-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Outcome data will be collected using the following standard scoring systems of which summary statistics will be provided:
• Constant and Murley Score to evaluate clinical parameters such as range of motion, power, level of pain and functional ability.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anatomical Shoulder Domelock System Study
NCT03312465
Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty
NCT03617107
Comprehensive Reverse Shoulder Data Collection
NCT03404778
Reverse Shoulder Prosthesis Study
NCT00764504
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder Bipolar System
NCT05358574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients will undergo pre-operative, intra-operative and post-operative physical examination, radiographic evaluation according to the hospital's routine procedure and collection of quality of life metrics. Follow-up evaluations are to be conducted at either 6 weeks or 6 months (according to the hospital's standard care plan) and thereafter at 1, 2, 5 and 10 years post hospital discharge.
There are 5 study centres taking part in this project enrolling in total a maximum of 160 patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inverse / Reverse Shoulder
Patient treated with a inverse / reverse shoulder device.
Inverse/Reverse Shoulder Arthroplasty
Implantation of the Anatomical Shoulder Inverse/Reverse System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inverse/Reverse Shoulder Arthroplasty
Implantation of the Anatomical Shoulder Inverse/Reverse System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sex - male and female.
* General Health - the patient should be able to undergo surgery and participate in a follow-up program based upon physical examination and medical history.
* Informed Consent - patient or patient's legal representative has signed a Patient Informed Consent form.
* Indications - Diagnosis of disease or trauma in the affected joint, including cuff-tear arthropathy, failure of prior rotator cuff surgery and irreparable rotator cuff tears associated with loss of glenohumeral stability with the indication for total shoulder arthroplasty.
* The deltoid muscle has to be intact in all 3 parts (clavicular, acromial as well as spinal).
Exclusion Criteria
* Patient is pregnant.
* Patient is unwilling or unable to cooperate in a follow-up program.
* Patient shows one of the following medical conditions - Chronic fracture, Acute fracture, Axillary nerve lesion, Severe loss of humeral or glenoid bone, Paralysis of the deltoid muscle, Active Infection
* Patient requires one of the following medical interventions - Implant Revision, Glenoid bone grafting, Autografts
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer, GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elliott Goff, PhD
Role: STUDY_CHAIR
Zimmer Biomet, Jr. Clinical Project Lead
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AZ Monica Antwerpen
Antwerp, , Belgium
HELIOS ENDO-Klinik Hamburg
Hamburg, , Germany
Vitos Orthopädische Klinik Kassel
Kassel, , Germany
Uniklinik Balgrist
Zurich, , Switzerland
The Pennine Acute Hospital NHS Trust
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-U02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.